In last week's European Society of Human Reproduction and Embryology meeting, A. Farrag from the Grimaldi Medical Group, IVF/ICSI Unit, Rome, Italy presented a study done in the Grimaldi Medical Center. The study wanted to show the effect of treating patients going through ICSI
due to idiopathic male infertility (male infertility, the cause of which is not known) and oligospermia
(very low sperm count) with recombinant human FSH (gonal-F) before the IVF-ICSI cycle.
The men who were treated received Gonal-F shots 3 times a week for 3 months.
The results were good. Compared to the control group, the clinical pregnancy and implantation rates were higher and the early pregnancy loss rate was lower.
I wasn't able to find where the research was published, but if you're going through ICSI for one of the above reasons, it seems worth looking into.
Labels: male factor